重组Anti-LATS2抗体[EPR23126-488] - BSA and Azide free
Anti-LATS2 antibody [EPR23126-488] - BSA and Azide free
- KO Validated
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal LATS2 antibody. Carrier free. Suitable for IP, WB and reacts with Human, Synthetic peptide - Human samples.
查看别名
KPM, LATS2, Serine/threonine-protein kinase LATS2, Kinase phosphorylated during mitosis protein, Large tumor suppressor homolog 2, Serine/threonine-protein kinase kpm, Warts-like kinase
- IP
Supplier Data
Immunoprecipitation - Anti-LATS2 antibody [EPR23126-488] - BSA and Azide free (AB280363)
This data was developed using ab243657, the same antibody clone in a different buffer formulation.
LATS2 was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate with ab243657 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab243657 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate 10 ug
Lane 2 : ab243657 IP in HeLa whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab243657 in HeLa whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 64 seconds
Fresh lysates were used in this WB.
All lanes:
Immunoprecipitation - Anti-LATS2 antibody [EPR23126-488] (<a href='/products/primary-antibodies/lats2-antibody-epr23126-488-ab243657'>ab243657</a>)
Predicted band size: 120 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-LATS2 antibody [EPR23126-488] - BSA and Azide free (AB280363)
This data was developed using ab243657, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Fresh lysates were used in this WB.
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 3 minutes
All lanes:
Western blot - Anti-LATS2 antibody [EPR23126-488] (<a href='/products/primary-antibodies/lats2-antibody-epr23126-488-ab243657'>ab243657</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), transfected with scrambled siRNA control, whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeting LATS2, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 120 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-LATS2 antibody [EPR23126-488] - BSA and Azide free (AB280363)
This data was developed using ab243657, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Fresh lysates were used in this WB.
Exposure time : 3 minutes
All lanes:
Western blot - Anti-LATS2 antibody [EPR23126-488] (<a href='/products/primary-antibodies/lats2-antibody-epr23126-488-ab243657'>ab243657</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 2:
HEK-293T (human embryonic kidney epithelial cell), whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 120 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-LATS2 antibody [EPR23126-488] - BSA and Azide free (AB280363)
This data was developed using ab243657, the same antibody clone in a different buffer formulation.
Western blot : Anti-LATS2 antibody [EPR23126-488] (ab243657) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab243657 was shown to bind specifically to LATS2. A band was observed at 117-171 kDa in wild-type A549 cell lysates with no signal observed at this size in LATS2 knockout cell line. To generate this image, wild-type and LATS2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-LATS2 antibody [EPR23126-488] (<a href='/products/primary-antibodies/lats2-antibody-epr23126-488-ab243657'>ab243657</a>) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
Western blot - Human LATS2 knockout A549 cell line (<a href='/products/cell-lines/human-lats2-knockout-a549-cell-line-ab286746'>ab286746</a>)
Lane 2:
LATS2 knockout A549 cell lysate at 20 µg
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
Raji cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 4:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 117-171 kDa
false
- WB
Lab
Western blot - Anti-LATS2 antibody [EPR23126-488] - BSA and Azide free (AB280363)
This data was developed using ab243657, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 3 minutes
All lanes:
Western blot - Anti-LATS2 antibody [EPR23126-488] (<a href='/products/primary-antibodies/lats2-antibody-epr23126-488-ab243657'>ab243657</a>) at 1/1000 dilution
Lane 1:
His-tagged human LATS1 recombinant protein (aa701-1054) at 0.01 µg
Lane 2:
His-tagged human LATS2 recombinant protein (aa664-1016) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 120 kDa
false
不同偶联物与剂型 (1)
-
Anti-LATS2 antibody [EPR23126-488]
反应性数据
产品详情
ab280363 is the carrier-free version of ab243657.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LATS2 plays an important role in cell cycle regulation and tumor suppression. LATS2 forms part of the core kinase complex within the Hippo pathway working closely with other proteins like MST1/2 kinases and Scaffold proteins SAV1. Through phosphorylation LATS2 can inhibit the activity of YAP and TAZ transcription co-activators promoting cell contact inhibition and proper tissue architecture. Its activity is important for limiting excessive cell growth and ensuring accurate cell division.
Pathways
LATS2 integrates into the Hippo signaling pathway and influences the PI3K-AKT signaling pathway. Within the Hippo pathway LATS2 interacts with MST1/2 forming an upstream kinase complex activating through phosphorylation of downstream transcription co-activators YAP and TAZ. These interactions result in the transcriptional regulation of genes controlling cell growth and apoptosis. Overlap with the PI3K-AKT pathway links LATS2 to cellular processes related to growth migration and survival providing a critical nexus that communicates cell status and environmental cues.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com